Regencell Bioscience Holdings annual net income
2019
2020
2021
2022
2023
2024
2025
Regencell Bioscience Holdings Net Income Growth & History (RGC)
Regencell Bioscience Holdings's net income was −$3.6M for fiscal 2025.
View full Regencell Bioscience Holdings company overviewRegencell Bioscience Holdings annual net income history
| Fiscal year | Period ended | Net income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | −$3.6M | $717,624 | — |
| 2024 | 2024-06-30 | −$4.3M | $1.6M | — |
| 2023 | 2023-06-30 | −$5.9M | $1.6M | — |
| 2022 | 2022-06-30 | −$7.4M | −$6.1M | — |
| 2021 | 2021-06-30 | −$1.3M | −$534,374 | — |
| 2020 | 2020-06-30 | −$812,371 | −$421,381 | — |
| 2019 | 2019-06-30 | −$390,990 | — | — |
Regencell Bioscience Holdings net income trends
Over the last five fiscal years, Regencell Bioscience Holdings's net income decreased from −$812,371 to −$3.6M, a change of −$2.8M.
About the metric
What net income means
Net income is a company’s bottom-line profit or loss after operating costs, interest, taxes, and other reported income and expenses. It shows how much of a company’s revenue ultimately remained as earnings, or how large its loss was, during a fiscal period.
Calculation and source
SEC-reported net income
TickerStat standardizes consolidated net income or profit and loss reported in company SEC filings for aligned fiscal periods. It is not adjusted earnings, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Regencell Bioscience Holdings source filings ↗